1448428-02-1

Basic information

• Product Name: 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methylbenzonitrile
• Synonyms: 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methylbenzonitrile
• CAS NO: 1448428-02-1
• Molecular Weight: 241.268
• Mol File: 1448428-02-1.mol

Chemical Properties

• CAS DataBase Reference: 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methylbenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methylbenzonitrile(1448428-02-1)
• EPA Substance Registry System: 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methylbenzonitrile(1448428-02-1)

Safety Data

• Hazardous Substances Data: 1448428-02-1(Hazardous Substances Data)

Upstream product

• 81447-28-1 2-cyclopropyl-2-oxoethyl 4-methylbenzenesulfonate 
• 765-43-5 Cyclopropyl methyl ketone 
• 1448428-01-0 5-(4-cyclopropyl-2-mercapto-1H-imidazol-1-yl)-2-fluoro-4-methylbenzonitrile 
• 1448428-00-9 5-((2-cyclopropyl-2-oxoethyl)amino)-2-fluoro-4-methylbenzonitrile 
• 1426136-04-0 5-amino-2-fluoro-4-methylbenzonitrile 
• 627871-16-3 5-bromo-4-fluoro-2-methylaniline 

Downstream Products

• 1448428-03-2 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methylbenzoic acid hydrochloride 
• 1448428-05-4 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide 
• 1448508-47-1 5-(4-cyclopropyl-1H-imidazole-1-yl)-2-fluoro-4-methylbenzoic acid 

Relevant articles and documents

AMIDE DERIVATIVE INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF

An amide derivative inhibitor and a preparation method and an application thereof. Specifically relating to the compound shown in general formula (I), a preparation method for same, a pharmaceutical composition comprising said compound, and an application of same as an ASK inhibitor for the treatment of neurodegenerative disease, cardiovascular disease, inflammation, autoimmune and metabolic disease, each of the substituents in the general formula (I) being as defined in the description.

PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF

Disclosed in the present invention are a compound as shown in formula (II), a tautomer or a pharmaceutically acceptable salt thereof, and also disclosed is the use thereof in preparing a drug for treating an ASK1-associated disease.

ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF

The present disclosure relates to a compound as shown in formula (II), a tautomer or a pharmaceutically acceptable salt thereof, and disclosed is the use thereof in preparing a drug for treating an ASK1-associated disease.

APOPTOSIS SIGNAL-REGULATING KINASE INHIBTOR

Provided is a compound of Formula (I) or a pharmaceutically acceptable salt thereof for use in treatment of non-alcoholic steatohepatitis, alcoholic hepatitis, pulmonary arterial hypertension, heart failure with preserved ejection fraction, and diabetic k

APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR

The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.